Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 3
1(100.0%)
1Total
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT07280065Phase 3Recruiting

REVEAL Study - Diagnostic Testing for PTSD Using the Senseye Diagnostic Tool

Role: lead

NCT05717439Completed

Feasibility and ML Training Investigation of the Senseye DT for Diagnosis of Adults with PTSD

Role: lead

NCT05372523Terminated

Senseye's OBCI Diagnostic Tool for PTSD

Role: lead

All 3 trials loaded